1. Home
  2. AZTR vs HTCR Comparison

AZTR vs HTCR Comparison

Compare AZTR & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azitra Inc

AZTR

Azitra Inc

HOLD

Current Price

$0.23

Market Cap

3.5M

Sector

Health Care

ML Signal

HOLD

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

HOLD

Current Price

$3.34

Market Cap

3.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZTR
HTCR
Founded
2014
2009
Country
United States
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
3.4M
IPO Year
2023
2022

Fundamental Metrics

Financial Performance
Metric
AZTR
HTCR
Price
$0.23
$3.34
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
453.5K
89.1K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
87.84%
EPS Growth
5.06
414.29
EPS
N/A
N/A
Revenue
N/A
$30,407,229.00
Revenue This Year
N/A
$123.26
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
39.19
52 Week Low
$0.10
$0.15
52 Week High
$1.40
$3.97

Technical Indicators

Market Signals
Indicator
AZTR
HTCR
Relative Strength Index (RSI) 51.63 57.75
Support Level $0.21 $2.74
Resistance Level $0.23 $3.85
Average True Range (ATR) 0.02 0.36
MACD 0.00 0.01
Stochastic Oscillator 74.80 65.35

Price Performance

Historical Comparison
AZTR
HTCR

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company providing solutions for digital transformation (DX). It develops, sells, and maintains CMS and CXM platforms using digital marketing technology, RPA, process mining solutions, myInvenio and Apromore, task mining solution CONTROLIO, and 3D-VR services including Matterport and VR360. The company also provides management consulting, education, services, and support to help customers succeed with the CXM Platform. It operates through two business units, the CX division for customer experience management and the DX division for digital transformation, which provides robotics process automation, process mining, and task mining. Its products include VR360, myInvenio, Apromore, and others, with maximum revenue from the United States.

Share on Social Networks: